Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Chest pain, Computerised tomogram neck, Computerised tomogram thorax, Dyspnoea exertional
Clinical narrative: multiple lymph nodes enlarged on US neck/hypermetabolic lymph nodes on CT; dyspnoea on exertion; Enlarged liver/spleen; Enlarged liver/spleen; Chest pains; Pulmonary edema; Pneumonia; IIH; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old female patient received BNT162b2 (BNT162B2), on 30Aug2021 as dose 2, single (Lot number: FD8448) at the age of 38 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Raynaud's", start date: 2008 (ongoing), notes: Raynaud's; "M.C.T.D", start date: 2015 (ongoing), notes: M.C.T.D, Under control/ managed since 2018; "CVA", start date: 23Jul2021 (unspecified if ongoing); "Enlarged lymph nodes", start date: Jul2021 (unspecified if ongoing), notes: Enlarged lymph nodes. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose: 1st, Site and route of injection: Right arm, Intramuscular, Batch/Lot number: FA7485), administration date: 23Jul2021, when the patient was 38-year-old, for COVID-19 Immunization, reaction(s): "CVA".  The following information was reported: IDIOPATHIC INTRACRANIAL HYPERTENSION (disability, medically significant) with onset Aug2021, outcome "not recovered", described as "IIH"; PNEUMONIA (medically significant) with onset Sep2021, outcome "unknown"; PULMONARY OEDEMA (disability, medically significant) with onset Sep2021, outcome "recovered", described as "Pulmonary edema"; CHEST PAIN (non-serious) with onset Nov2021, outcome "unknown", described as "Chest pains"; SPLENOMEGALY (non-serious), HEPATOMEGALY (non-serious) all with onset Jan2022, outcome "unknown" and all described as "Enlarged liver/spleen"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "multiple lymph nodes enlarged on US neck/hypermetabolic lymph nodes on CT"; DYSPNOEA EXERTIONAL (non-serious), outcome "unknown", described as "dyspnoea on exertion". The event "iih" required physician office visit. The event "pulmonary edema" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Chest X-ray: (Sep2021) Abnormal, notes: Lung opacity/edema; (Nov2021) Normal, notes: No acute disease; (Mar2022) Normal; Computerised tomogram neck: (Jan2022) Normal, notes: Multiple enlarged lymph node (word not legible) more on back; Computerised tomogram thorax: (Jan2022) Normal, notes: Multiple enlarged lymph node (word not legible); Us neck: (Jan2022) Multiple enlarged lymph nodes; Lumbar puncture: (Aug2021) Abnormal, notes: High opening neck pressure; Magnetic resonance imaging head: (Jan2022) Abnormal, notes: Venous anomaly; Oxygen saturation: (Mar2022) Dyspnea on exertion; Positron emission tomogram: (May2022) Abnormal, notes: Hypermetabolic lymph nodes with high uptake -So much more labs, test on (word not legible). Therapeutic measures were taken as a result of idiopathic intracranial hypertension, pulmonary oedema.